These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5950914)

  • 21. Multiple harvest technic for production of parainfluenza and measles hemagglutinating antigens.
    Palmer DF; Bucca MA
    Health Lab Sci; 1967 Apr; 4(2):126-8. PubMed ID: 4290560
    [No Abstract]   [Full Text] [Related]  

  • 22. Growth of Igbo-Ora virus in some tissue cultures.
    Olaleye OD; Omilabu SA; Baba SS
    Acta Virol; 1990 Aug; 34(4):367-71. PubMed ID: 1981449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A more rapid method of measles neutralization test with simultaneous cell inoculation.
    Strauss J; Zdrazilek J
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(1):47-54. PubMed ID: 5752390
    [No Abstract]   [Full Text] [Related]  

  • 24. [Serological diagnosis of transmissible gastroenteritis in swine].
    Liebermann H
    Arch Exp Veterinarmed; 1969; 23(4):811-26. PubMed ID: 4990544
    [No Abstract]   [Full Text] [Related]  

  • 25. The lyophilization of measles virus.
    Mares I; Kittnar E; Srbová H; Casný J
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(3):279-87. PubMed ID: 5387794
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antibovipestic protection conferred to cattle by a measles virus adapted to bovine cells].
    Provost A; Borredon C; Maurice Y
    C R Acad Hebd Seances Acad Sci D; 1967 Jun; 264(25):2961-4. PubMed ID: 4965038
    [No Abstract]   [Full Text] [Related]  

  • 27. [A simple method for the preparation of high grade complement fixing enterovirus antigen].
    Kuwert E; Thraenhart O
    Arch Hyg Bakteriol; 1966 Apr; 150(1):157-70. PubMed ID: 4297428
    [No Abstract]   [Full Text] [Related]  

  • 28. Assay of potency of inactivated measles virus vaccine by the antibody-combining test.
    Toyoshima K; Kitawaki T; Otsu K
    Biken J; 1966 Jun; 9(2):103-6. PubMed ID: 5913577
    [No Abstract]   [Full Text] [Related]  

  • 29. The complement-fixing antigen of rubella virus.
    Schmidt NJ; Lennette EH
    Proc Soc Exp Biol Med; 1966 Jan; 121(1):243-50. PubMed ID: 5902940
    [No Abstract]   [Full Text] [Related]  

  • 30. Rubella complement-fixing antigens derived from the fluid and cellular phases of infected BHK-21 cells: extraction of cell-associated antigen with alkaline buffers.
    Schmidt NJ; Lennette EH
    J Immunol; 1966 Dec; 97(6):815-21. PubMed ID: 5955833
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the serological standardization of measles virus.
    Toyoshima K; Kitawaki T; Otsu K; Mutai M; Omura S; Kunita N
    Biken J; 1965 Jun; 8(2):87-94. PubMed ID: 5837768
    [No Abstract]   [Full Text] [Related]  

  • 32. Rubella complement fixing antigen prepared by alkaline extraction of virus grown in suspension culture of BHK-211 cells.
    Halonen PD; Casey HL; Stewart JA; Hall AD
    Proc Soc Exp Biol Med; 1967 May; 125(1):167-72. PubMed ID: 6027518
    [No Abstract]   [Full Text] [Related]  

  • 33. Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay.
    Cohen BJ; Parry RP; Doblas D; Samuel D; Warrener L; Andrews N; Brown D
    J Virol Methods; 2006 Feb; 131(2):209-12. PubMed ID: 16188328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PRODUCTION OF SV-40 COMPLEMENT-FIXING ANTIGEN.
    SCHELL KR
    Nature; 1964 Jul; 203():417-8. PubMed ID: 14197394
    [No Abstract]   [Full Text] [Related]  

  • 35. [Standardization of neutralization tests using the COBL cell line and comparison with the particle agglutination test for measles serology].
    Korukluoğlu G; Yalçinkaya T; Ozkaya E; Kurtoğlu D; Gözalan A; Miyamura K
    Mikrobiyol Bul; 2002 Apr; 36(2):193-9. PubMed ID: 12652872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison between the plaque reduction neutralization test and the hemagglutination inhibition test in determination of human anti-measles antibodies].
    Kong J; Guo SH; Ze WY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Apr; 17(2):105-7. PubMed ID: 8758407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of vital staining of tissue culture in working with measles virus].
    Seĭbil' VB; Khozinskiĭ VI
    Vopr Virusol; 1967; 12(2):246-9. PubMed ID: 4177013
    [No Abstract]   [Full Text] [Related]  

  • 38. Micro method for performing titration and neutralization test of hog cholera virus using established porcine kidney cell strain.
    Komaniwa H; Fukusho A; Shimizu Y
    Natl Inst Anim Health Q (Tokyo); 1981; 21(4):153-8. PubMed ID: 7200574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenic variants of arboviruses. 3. Host passage selection of constituent antigen subpopulations of strains.
    Henderson JR; Levine SI; Stim TB; Karabatsos N
    J Immunol; 1967 Nov; 99(5):935-44. PubMed ID: 6065110
    [No Abstract]   [Full Text] [Related]  

  • 40. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization.
    de Swart RL; Yüksel S; Osterhaus AD
    J Virol; 2005 Sep; 79(17):11547-51. PubMed ID: 16103210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.